221 related articles for article (PubMed ID: 19015604)
1. Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats.
Kato N; Liang YQ; Ochiai Y; Birukawa N; Serizawa M; Jesmin S
Hypertens Res; 2008 Oct; 31(10):1963-75. PubMed ID: 19015604
[TBL] [Abstract][Full Text] [Related]
2. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
3. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
Kato N; Liang YQ; Ochiai Y; Jesmin S
Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
5. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
7. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
[TBL] [Abstract][Full Text] [Related]
8. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: gene expression profiles in the brain.
Yoshida M; Watanabe Y; Yamanishi K; Yamashita A; Yamamoto H; Okuzaki D; Shimada K; Nojima H; Yasunaga T; Okamura H; Matsunaga H; Yamanishi H
Int J Mol Med; 2014 Apr; 33(4):887-96. PubMed ID: 24452243
[TBL] [Abstract][Full Text] [Related]
12. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
De Cavanagh EM; Toblli JE; Ferder L; Piotrkowski B; Stella I; Fraga CG; Inserra F
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):573-8. PubMed ID: 16309582
[TBL] [Abstract][Full Text] [Related]
14. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
Takemori K; Ishida H; Ito H
Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
[TBL] [Abstract][Full Text] [Related]
15. Superoxide dismutase mimetic, tempol, aggravates renal injury in advanced-stage stroke-prone spontaneously hypertensive rats.
Sugama I; Kohagura K; Yamazato M; Nakamura T; Shinzato T; Ohya Y
J Hypertens; 2014 Mar; 32(3):534-41. PubMed ID: 24309490
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of the renin-angiotensin and associated systems in the rat after pharmacological and dietary interventions in vivo.
Ochiai Y; Liang YQ; Serizawa M; Kato N
Physiol Genomics; 2008 Nov; 35(3):330-40. PubMed ID: 18796534
[TBL] [Abstract][Full Text] [Related]
17. The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan.
Ishii M; Hattori A; Numaguchi Y; Tsujimoto M; Ishiura S; Kobayashi H; Murohara T; Wright JW; Mizutani S
Horm Metab Res; 2008 Dec; 40(12):887-91. PubMed ID: 18726831
[TBL] [Abstract][Full Text] [Related]
18. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
19. Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats.
Mazza ON; Angerosa M; Becher E; Toblli JE
J Sex Med; 2006 Jul; 3(4):604-611. PubMed ID: 16839316
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]